Basit öğe kaydını göster

dc.contributor.authorGok, Ozlem
dc.contributor.authorErgen, Hayriye Arzu
dc.contributor.authorZeybek, Umit
dc.contributor.authorKaraali, Z. Ermis
dc.date.accessioned2021-03-06T12:33:22Z
dc.date.available2021-03-06T12:33:22Z
dc.date.issued2012
dc.identifier.citationErgen H. A. , Zeybek U., Gok O., Karaali Z. E. , "Investigation of ABCA1 C69T polymorphism in patients with type 2 diabetes mellitus.", Biochemia medica, cilt.22, ss.114-20, 2012
dc.identifier.issn1330-0962
dc.identifier.othervv_1032021
dc.identifier.otherav_f46a5afc-986b-4720-9602-dc91c3ee3ef6
dc.identifier.urihttp://hdl.handle.net/20.500.12627/160241
dc.identifier.urihttps://doi.org/10.11613/bm.2012.013
dc.description.abstractIntroduction: Non insulin dependent diabetes mellitus is the most common type of diabetes. Genetic factors, lipid profiles, hypertension are potential risk factors for diabetes mellitus. Adenosine binding cassette transporter proteins 1 (ABCA1) plays a role in cholesterol metabolism, especially high density lipoprotein (HDL-cholesterol). There are multiple mechanisms by which HDL-cholesterol can be atheroprotective, it is clear that the relative activity of ABCA1 plays a major role. We aimed to investigate association of ABCA1 C69T gene polymorphism with lipid levels in Turkish type 2 diabetic patients.
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectTIBBİ LABORATUVAR TEKNOLOJİSİ
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.titleInvestigation of ABCA1 C69T polymorphism in patients with type 2 diabetes mellitus.
dc.typeMakale
dc.relation.journalBiochemia medica
dc.contributor.departmentIstanbul Haseki Training & Research Hospital , ,
dc.identifier.volume22
dc.identifier.issue1
dc.identifier.startpage114
dc.identifier.endpage20
dc.contributor.firstauthorID75616


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster